NeoGenomics, Inc. Increase (Decrease) in Other Noncurrent Assets
NeoGenomics, Inc. (NEO) reported Increase (Decrease) in Other Noncurrent Assets of $1.16 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-24.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2023-02-24
- NeoGenomics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2015-12-31 was $1.00K.
- NeoGenomics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2015-09-30 was $1.00K.
- NeoGenomics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2015-06-30 was -$12.00K.
- NeoGenomics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2015-03-31 was -$1.00K, a 104.00% decline year-over-year.
- NeoGenomics, Inc. increase (decrease) in other noncurrent assets for fiscal 2022 was $1.16M, a 39.14% decline from fiscal 2021.
- NeoGenomics, Inc. increase (decrease) in other noncurrent assets for fiscal 2021 was $1.91M, a 80.45% decline from fiscal 2020.
- NeoGenomics, Inc. increase (decrease) in other noncurrent assets for fiscal 2020 was $9.75M, a 2556.68% increase from fiscal 2019.
- NeoGenomics, Inc. increase (decrease) in other noncurrent assets for fiscal 2019 was $367.00K, a 79.99% decline from fiscal 2018.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month | Increase (Decrease) in Other Noncurrent Assets 12 month as first filed |
|---|---|---|---|---|---|
| 2022-12-31 | $1.16M 10-K · filed 2023-02-24 | ||||
| 2021-12-31 | $1.91M 10-K · filed 2023-02-24 | ||||
| 2020-12-31 | $9.75M 10-K · filed 2023-02-24 | ||||
| 2019-12-31 | $367.00K 10-K · filed 2022-02-25 | $133.00K 10-K · filed 2020-02-28 | |||
| 2018-12-31 | $1.83M 10-K · filed 2021-02-25 | -$96.00K 10-K · filed 2019-02-26 | |||
| 2017-12-31 | $475.00K 10-K · filed 2020-02-28 | $29.00K 10-K · filed 2018-03-13 | |||
| 2016-12-31 | $44.00K 10-K · filed 2019-02-26 | ||||
| 2015-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | $2.00K derived: sum of 2 quarters · filed 2018-03-13 | -$10.00K derived: sum of 3 quarters · filed 2018-03-13 | -$11.00K 10-K · filed 2018-03-13 | |
| 2015-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | -$11.00K derived: sum of 2 quarters · filed 2015-11-06 | -$12.00K 10-Q · filed 2015-11-06 | -$14.00K derived: sum of 4 quarters · filed 2017-03-14 | |
| 2015-06-30 | -$12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-31 | -$13.00K 10-Q · filed 2015-07-31 | -$15.00K derived: sum of 3 quarters · filed 2017-03-14 | -$16.00K derived: sum of 4 quarters · filed 2017-03-14 | |
| 2015-03-31 | -$1.00K 10-Q · filed 2015-05-11 | -$3.00K derived: sum of 2 quarters · filed 2017-03-14 | -$4.00K derived: sum of 3 quarters · filed 2017-03-14 | -$67.00K derived: sum of 4 quarters · filed 2017-03-14 | |
| 2014-12-31 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | -$3.00K derived: sum of 2 quarters · filed 2017-03-14 | -$66.00K derived: sum of 3 quarters · filed 2017-03-14 | -$41.00K 10-K · filed 2017-03-14 | |
| 2014-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | -$64.00K derived: sum of 2 quarters · filed 2015-11-06 | -$39.00K 10-Q · filed 2015-11-06 | -$63.00K derived: sum of 4 quarters · filed 2016-04-18 | |
| 2014-06-30 | -$63.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-31 | -$38.00K 10-Q · filed 2015-07-31 | -$62.00K derived: sum of 3 quarters · filed 2016-04-18 | -$54.00K derived: sum of 4 quarters · filed 2016-04-18 | |
| 2014-03-31 | $25.00K 10-Q · filed 2015-05-11 | $1.00K derived: sum of 2 quarters · filed 2016-04-18 | $9.00K derived: sum of 3 quarters · filed 2016-04-18 | ||
| 2013-12-31 | -$24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-18 | -$16.00K derived: sum of 2 quarters · filed 2016-04-18 | $71.00K 10-K · filed 2016-04-18 | ||
| 2013-09-30 | $8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | $95.00K 10-Q · filed 2014-11-04 | |||
| 2013-06-30 | $87.00K 10-Q · filed 2014-07-29 | ||||
| 2012-12-31 | -$8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-03 | -$40.00K derived: sum of 2 quarters · filed 2015-03-03 | -$46.00K 10-K · filed 2015-03-03 | ||
| 2012-09-30 | -$32.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30 | -$38.00K 10-Q · filed 2013-10-30 | |||
| 2012-06-30 | -$6.00K 10-Q · filed 2013-08-02 | ||||
| 2011-12-31 | $18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-24 | $55.00K 10-K · filed 2014-02-24 | |||
| 2011-09-30 | $37.00K 10-Q · filed 2012-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |